Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Zimmer Biomet Holdings, Inc. (ZBH) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▼ Bearish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Bottom 35% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $17.58B large-cap · #4 of 24 peers
Summary

Zimmer Biomet Holdings, Inc. (ZBH) stock forecast summary

Our AI ranks Zimmer Biomet Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Zimmer Biomet Holdings, Inc. is a large-cap company with a market capitalization of $17.58B. It ranks number 4 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.

A per-ticker accuracy statistic for ZBH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, ZBH included.

Follow ZBH free
Price

ZBH price chart and AI forecast

ZBH
Cross-section · 2026-10-13

How ZBH ranks among 5379 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Zimmer Biomet Holdings, Inc. (ZBH) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.

Valuation & Market

MetricZBHIndustry medianRank
Market Cap $17.58B $132M 4/24
P/E Ratio 21.79x 24.66x 6/7
P/B Ratio 1.39x 2.96x 14/19
Dividend Yield 1.07% – –
EPS $5.03 – –
Book Value/Share $66.18 – –
Revenue/Share $44.61 – –
FCF/Share $7.98 – –

Profitability & Margins

MetricZBHIndustry medianRank
ROE 6.4% -36.1% 7/20
ROA 3.5% -16.5% 7/20
ROIC 6.1% -6.5% 9/21
Gross Margin 69.9% 50.1% 4/20
Operating Margin 14.2% -8.7% 4/21
Net Margin 9.5% -14.9% 5/18
EBT Margin 11.0% -19.3% 5/21
Tax Rate 13.6% – –

Financial Health

MetricZBHIndustry medianRank
Current Ratio 1.69x 2.55x 21/24
Quick Ratio 0.94x 2.01x 20/21
D/E Ratio 0.81x 0.65x 10/23
Financial Leverage 1.81x 1.65x 10/23
Working Capital $2.08B $71M 2/22

Cash Flow

MetricZBHIndustry medianRank
Operating Cash Flow $1.74B -$680K 2/22
Free Cash Flow $1.52B $2M 2/16
Capital Spending -$220M -$2M 15/16
OCF Growth YoY 4.8% 26.3% 8/9
FCF Growth YoY 3.4% 61.6% 6/7
FCF/Sales 17.9% 1.2% 3/16
CapEx/Sales 2.6% 1.3% 7/16

Operational Efficiency

MetricZBHIndustry medianRank
Asset Turnover 0.37x 0.72x 15/18
Receivables Turnover 4.8x 5.5x 11/16
Inventory Turnover 1.1x 2.1x 16/21
Fixed Assets Turnover 3.8x 6.2x 12/18
Days Sales Outstanding 76 days 67 days 6/16
Days Inventory 323 days 177 days 6/21
Payables Period 50 days 53 days 11/18
Cash Conversion Cycle 349 days 140 days 2/15

Income Statement

MetricZBHIndustry medianRank
Total Revenue $8.51B $150M 2/18
Operating Income $1.21B -$6M 2/22
Net Income $806M -$5M 2/18
R&D Expense $443M $19M 2/19
SG&A Expense $3.43B $80M 1/19
Cost of Goods Sold $2.56B $55M 3/20

Dividend & Shareholder Information

MetricZBHIndustry medianRank
Dividends Per Share $0.99 – –
Payout Ratio 19.7% – –
Shares Outstanding 191M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$5.10B22.4% of assets
Cash & Short-term Investments$410M1.8% of assets
Accounts Receivable$1.77B7.8% of assets
Inventory$2.27B10.0% of assets
Total Liabilities$10.17B44.6% of assets
Short-term Debt$2.66B11.7% of assets
Quarterly Financial Reports

ZBH quarterly financials and insider trading

Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet Holdings, Inc. (ZBH) industry peers

Companies classified under the same SEC industry code as Zimmer Biomet Holdings, Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
ZBH Zimmer Biomet Holdings, Inc. ▼ $17.58B 21.8x 1.4x
ISRG Intuitive Surgical Inc ▼ $149.10B 47.5x 8.2x
SNN Smith & Nephew Plc ▼ $24.45B – –
STE Steris Plc ▼ $21.35B 26.5x 3.0x
ALGN Align Technology Inc ▼ $10.20B 24.7x 2.4x
MSA Msa Safety Inc ▼ $7.01B 22.3x 5.0x
ESTA Establishment Labs Holdings Inc. ▲ $1.74B – 80.6x
CDRE Cadre Holdings, Inc. ▶ $1.12B 31.1x 3.2x
ENOV Enovis Corp ▶ $1.10B – 0.7x
AVR Anteris Technologies Global Corp. ▼ $629M – 2.5x
SMTI Sanara Medtech Inc. ▼ $323M – 40.7x
INGN Inogen Inc ▶ $168M – 1.0x
LAKE Lakeland Industries Inc ▲ $97M – 0.8x
NTRB Nutriband Inc. ▲ $71M – 13.3x
APT Alpha Pro Tech Ltd ▲ $59M 13.9x 0.9x
MYO Myomo, Inc. ▲ $51M – 8.8x
COCH Envoy Medical, Inc. ▶ $50M – –
MLSS Milestone Scientific Inc. ▲ $31M – 8.9x
LFWD Lifeward Ltd. ▲ $18M – 1.4x
UEEC United Health Products, Inc. ▶ $12M – –
RGNT Regentis Biomaterials Ltd. ▼ $8M – 4.4x
CLGN Collplant Biotechnologies Ltd ▶ $5M – 0.9x
RBOT Vicarious Surgical Inc. ▼ $360K – –
FEED Envue Medical, Inc. ▼ $320K – –
BBLG Bone Biologics Corp ▶ N/A – –
CUPR Cuprina Holdings (Cayman) Ltd ▼ N/A – –
LGMK Logicmark, Inc. ▼ N/A – –

Where ZBH sits on the market map

Industrial Applications and Services · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Explore the map →
News

Zimmer Biomet Holdings, Inc. (ZBH) stock news

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More
FAQ

Zimmer Biomet Holdings, Inc. (ZBH) stock forecast FAQ

What is the Zimmer Biomet Holdings, Inc. (ZBH) stock forecast?

Our AI ranks Zimmer Biomet Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Zimmer Biomet Holdings, Inc. stock predictions?

A per-ticker accuracy statistic for ZBH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Zimmer Biomet Holdings, Inc. forecasts updated?

Zimmer Biomet Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Zimmer Biomet Holdings, Inc.'s industry peers?

27 issuers in our coverage, ZBH included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Align Technology Inc (ALGN), Msa Safety Inc (MSA), Establishment Labs Holdings Inc. (ESTA).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.